English

NEXSTAR PHARMACEUTICALS INC

EDGAR

Annual report amendment (10-K/A) · filed 1999-06-23

15 filing records in this dataset, filed from 1996-05-15 to 1999-06-23. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

33.3 million USD

1999-03-31 · USD

Exact inputs and evidence

Revenue: 33339000 USD Source

Operating margin

8.07%

1999-03-31 · %

Exact inputs and evidence

Operating Income: 2689000 USD Source
Revenue: 33339000 USD Source

Operating cash flow

5.53 million USD

1999-03-31 · USD

Exact inputs and evidence

Operating Cash Flow: 5527000 USD Source

Free cash flow

4.18 million USD

1999-03-31 · USD

Exact inputs and evidence

Operating Cash Flow: 5527000 USD Source
Capital Expenditure: 1344000 USD Source

Cash and cash equivalents: 71 million USD 1999-03-31 Source
Exact value

70961000 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

123 million USD

1998-04-01 – 1999-03-31

Exact inputs and evidence

Revenue: 29025000 USD · 1998-04-01 – 1998-06-30 Source
Revenue: 29705000 USD · 1998-07-01 – 1998-09-30 Source
Revenue: 118549000 USD · 1998-01-01 – 1998-12-31 Source
Revenue: 87413000 USD · 1998-01-01 – 1998-09-30 Source
Revenue: 33339000 USD · 1999-01-01 – 1999-03-31 Source

Net income

13.8 million USD

1998-04-01 – 1999-03-31

Exact inputs and evidence

Net income: -3352000 USD · 1998-04-01 – 1998-06-30 Source
Net income: 19460000 USD · 1998-07-01 – 1998-09-30 Source
Net income: 10920000 USD · 1998-01-01 – 1998-12-31 Source
Net income: 13527000 USD · 1998-01-01 – 1998-09-30 Source
Net income: 311000 USD · 1999-01-01 – 1999-03-31 Source

Operating cash flow

7.99 million USD

1998-04-01 – 1999-03-31

Exact inputs and evidence

Operating cash flow: -5482000 USD · 1998-01-01 – 1998-06-30 Source
Operating cash flow: -3768000 USD · 1998-01-01 – 1998-03-31 Source
Operating cash flow: -7078000 USD · 1998-01-01 – 1998-09-30 Source
Operating cash flow: -5482000 USD · 1998-01-01 – 1998-06-30 Source
Operating cash flow: -1304000 USD · 1998-01-01 – 1998-12-31 Source
Operating cash flow: -7078000 USD · 1998-01-01 – 1998-09-30 Source
Operating cash flow: 5527000 USD · 1999-01-01 – 1999-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 1999-06-23.

Financial data available through: 1998-12-31.

Coverage by financial measure

Revenue: 5 of 11 periods available· newest 1998-12-31
Operating income: 3 of 11 periods available· newest 1998-12-31
Net income: 5 of 11 periods available· newest 1998-12-31
Operating cash flow: 5 of 11 periods available· newest 1998-12-31
Capital expenditure: 5 of 11 periods available· newest 1998-12-31
Total assets: 4 of 11 periods available· newest 1998-12-31
liabilities: No compatible figures in this window
Current assets: 4 of 11 periods available· newest 1998-12-31
Current liabilities: 4 of 11 periods available· newest 1998-12-31
Cash and cash equivalents: 5 of 11 periods available· newest 1998-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+28.5%

Prior period

USD 92.22 million

1997-01-01 – 1997-12-31
Current period

USD 118.55 million

1998-01-01 – 1998-12-31

Exact inputs and evidence

118549000 − 92221000 = 26328000 USD

92221000 USD · 1997-01-01 – 1997-12-31
Inspect prior input Prior source
118549000 USD · 1998-01-01 – 1998-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · NEXSTAR PHARMACEUTICALS INC · 1998-12-31 NEXSTAR PHARMACEUTICALS INC (edgar:915359) Year-over-year change in Revenue: 26328000 USD Concept: fundies:Revenue Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-10T02:58:16Z Snapshot: 10d6762f766f08be52a0594ecc2f9707db653b3d6600cbb2e82764f817e5d746 Dimensions: Consolidated View: https://fundies.io/companies/edgar/915359?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 118549000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/915359/0001047469-99-025026.txt#4270 Input fundies:Revenue: 92221000 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/915359/0001047469-99-025026.txt#4270
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 54.83 million

Prior period

−USD 43.91 million

1997-01-01 – 1997-12-31
Current period

USD 10.92 million

1998-01-01 – 1998-12-31

Exact inputs and evidence

10920000 − -43910000 = 54830000 USD

-43910000 USD · 1997-01-01 – 1997-12-31
Inspect prior input Prior source
10920000 USD · 1998-01-01 – 1998-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · NEXSTAR PHARMACEUTICALS INC · 1998-12-31 NEXSTAR PHARMACEUTICALS INC (edgar:915359) Year-over-year change in Net income: 54830000 USD Concept: fundies:NetIncome Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-10T02:58:16Z Snapshot: 10d6762f766f08be52a0594ecc2f9707db653b3d6600cbb2e82764f817e5d746 Dimensions: Consolidated View: https://fundies.io/companies/edgar/915359?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: 10920000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/915359/0001047469-99-025026.txt#4404 Input fundies:NetIncome: -43910000 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/915359/0001047469-99-025026.txt#4404
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 28.16 million

Prior period

−USD 29.46 million

1997-01-01 – 1997-12-31
Current period

−USD 1.3 million

1998-01-01 – 1998-12-31

Exact inputs and evidence

-1304000 − -29459000 = 28155000 USD

-29459000 USD · 1997-01-01 – 1997-12-31
Inspect prior input Prior source
-1304000 USD · 1998-01-01 – 1998-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · NEXSTAR PHARMACEUTICALS INC · 1998-12-31 NEXSTAR PHARMACEUTICALS INC (edgar:915359) Year-over-year change in Operating cash flow: 28155000 USD Concept: fundies:OperatingCashFlow Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-10T02:58:16Z Snapshot: 10d6762f766f08be52a0594ecc2f9707db653b3d6600cbb2e82764f817e5d746 Dimensions: Consolidated View: https://fundies.io/companies/edgar/915359?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -1304000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/915359/0001047469-99-025026.txt#4430 Input fundies:OperatingCashFlow: -29459000 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/915359/0001047469-99-025026.txt#4430
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-21%

Prior period

USD 10.48 million

1997-01-01 – 1997-12-31
Current period

USD 8.28 million

1998-01-01 – 1998-12-31

Exact inputs and evidence

8281000 − 10484000 = -2203000 USD

10484000 USD · 1997-01-01 – 1997-12-31
Inspect prior input Prior source
8281000 USD · 1998-01-01 – 1998-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · NEXSTAR PHARMACEUTICALS INC · 1998-12-31 NEXSTAR PHARMACEUTICALS INC (edgar:915359) Year-over-year change in Capital expenditure: -2203000 USD Concept: fundies:CapitalExpenditure Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-10T02:58:16Z Snapshot: 10d6762f766f08be52a0594ecc2f9707db653b3d6600cbb2e82764f817e5d746 Dimensions: Consolidated View: https://fundies.io/companies/edgar/915359?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 8281000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/915359/0001047469-99-025026.txt#4435 Input fundies:CapitalExpenditure: 10484000 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/915359/0001047469-99-025026.txt#4435
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

1998 1998-01-01 – 1998-12-31

Revenue USD 118.55 million 100% of revenue
Cost of revenue USD 21.33 million 18% of revenue
Operating expenses USD 101.94 million 86% of revenue
Other operating costs Derived USD 1.27 million 1.1% of revenue
Operating income −USD 5.98 million −5% of revenue
Tax, interest and other Derived −USD 16.9 million −14% of revenue
Net income USD 10.92 million 9.2% of revenue

Cash

Operating cash flow −USD 1.3 million −1.1% of revenue
Capital expenditure USD 8.28 million 7% of revenue
Free cash flow Derived −USD 9.59 million −8.1% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

1994 Not shown: operating income or net income is not reported.
1995 Not shown: operating income or net income is not reported.
1996 Operating loss: operating costs were 125% of revenue.
1997 Operating loss: operating costs were 145% of revenue.
1998 Operating loss: operating costs were 105% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
1994 1994-01-01 – 1994-12-31	50430000	Unavailable	Unavailable	Unavailable	-16207000	-36578000 Derived	Source 1994-01-01 – 1994-12-31: 50430000 USD Inspect Revenue Open source 1994-01-01 – 1994-12-31: -16207000 USD Inspect Net Income Open source 1994-01-01 – 1994-12-31: -12883000 USD Inspect Operating Cash Flow Open source 1994-01-01 – 1994-12-31: 23695000 USD Inspect Capital Expenditure Open source
1995 1995-01-01 – 1995-12-31	62426000	Unavailable	Unavailable	Unavailable	-36631000	-25741000 Derived	Source 1995-01-01 – 1995-12-31: 62426000 USD Inspect Revenue Open source 1995-01-01 – 1995-12-31: -36631000 USD Inspect Net Income Open source 1995-01-01 – 1995-12-31: -17078000 USD Inspect Operating Cash Flow Open source 1995-01-01 – 1995-12-31: 8663000 USD Inspect Capital Expenditure Open source
1996 1996-01-01 – 1996-12-31	88701000	111019000 Derived	-22318000	663000 Derived	-22981000	-31529000 Derived	Source 1996-01-01 – 1996-12-31: 88701000 USD Inspect Revenue Open source 1996-01-01 – 1996-12-31: -22318000 USD Inspect Operating Income Open source 1996-01-01 – 1996-12-31: -22981000 USD Inspect Net Income Open source 1996-01-01 – 1996-12-31: -20331000 USD Inspect Operating Cash Flow Open source 1996-01-01 – 1996-12-31: 11198000 USD Inspect Capital Expenditure Open source
1997 1997-01-01 – 1997-12-31	92221000	133866000 Derived	-41645000	2265000 Derived	-43910000	-39943000 Derived	Source 1997-01-01 – 1997-12-31: 92221000 USD Inspect Revenue Open source 1997-01-01 – 1997-12-31: -41645000 USD Inspect Operating Income Open source 1997-01-01 – 1997-12-31: -43910000 USD Inspect Net Income Open source 1997-01-01 – 1997-12-31: -29459000 USD Inspect Operating Cash Flow Open source 1997-01-01 – 1997-12-31: 10484000 USD Inspect Capital Expenditure Open source
1998 1998-01-01 – 1998-12-31	118549000	124533000 Derived	-5984000	-16904000 Derived	10920000	-9585000 Derived	Source 1998-01-01 – 1998-12-31: 118549000 USD Inspect Revenue Open source 1998-01-01 – 1998-12-31: -5984000 USD Inspect Operating Income Open source 1998-01-01 – 1998-12-31: 10920000 USD Inspect Net Income Open source 1998-01-01 – 1998-12-31: -1304000 USD Inspect Operating Cash Flow Open source 1998-01-01 – 1998-12-31: 8281000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 118.5M 1998

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
19941994-12-31	Revenue	50430000	Revenue: 50430000 Open source
19951995-12-31	Revenue	62426000	Revenue: 62426000 Open source
19961996-12-31	Revenue	88701000	Revenue: 88701000 Open source
19971997-12-31	Revenue	92221000	Revenue: 92221000 Open source
19981998-12-31	Revenue	118549000	Revenue: 118549000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

28.5% 1998

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
19941994-12-31	Year over year	No prior comparable period	Revenue: 50430000 Open source
19951995-12-31	Year over year	23.8%	Revenue: 62426000 Open source Revenue: 50430000 Open source
19961996-12-31	Year over year	42.1%	Revenue: 88701000 Open source Revenue: 62426000 Open source
19971997-12-31	Year over year	4%	Revenue: 92221000 Open source Revenue: 88701000 Open source
19981998-12-31	Year over year	28.5%	Revenue: 118549000 Open source Revenue: 92221000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -5% 1998

Net margin 9.2% 1998

Free cash flow margin -8.1% 1998

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
1994-12-31	Operating margin	Not reported	Revenue: 50430000 Open source
1995-12-31	Operating margin	Not reported	Revenue: 62426000 Open source
19961996-12-31	Operating margin	-25.2%	Operating Income: -22318000 Open source Revenue: 88701000 Open source
19971997-12-31	Operating margin	-45.2%	Operating Income: -41645000 Open source Revenue: 92221000 Open source
19981998-12-31	Operating margin	-5%	Operating Income: -5984000 Open source Revenue: 118549000 Open source
19941994-12-31	Net margin	-32.1%	Net Income: -16207000 Open source Revenue: 50430000 Open source
19951995-12-31	Net margin	-58.7%	Net Income: -36631000 Open source Revenue: 62426000 Open source
19961996-12-31	Net margin	-25.9%	Net Income: -22981000 Open source Revenue: 88701000 Open source
19971997-12-31	Net margin	-47.6%	Net Income: -43910000 Open source Revenue: 92221000 Open source
19981998-12-31	Net margin	9.2%	Net Income: 10920000 Open source Revenue: 118549000 Open source
19941994-12-31	Free cash flow margin	-72.5%	Revenue: 50430000 Open source Operating Cash Flow: -12883000 Open source Capital Expenditure: 23695000 Open source
19951995-12-31	Free cash flow margin	-41.2%	Revenue: 62426000 Open source Operating Cash Flow: -17078000 Open source Capital Expenditure: 8663000 Open source
19961996-12-31	Free cash flow margin	-35.5%	Revenue: 88701000 Open source Operating Cash Flow: -20331000 Open source Capital Expenditure: 11198000 Open source
19971997-12-31	Free cash flow margin	-43.3%	Revenue: 92221000 Open source Operating Cash Flow: -29459000 Open source Capital Expenditure: 10484000 Open source
19981998-12-31	Free cash flow margin	-8.1%	Revenue: 118549000 Open source Operating Cash Flow: -1304000 Open source Capital Expenditure: 8281000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -1.3M 1998

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19941994-12-31	Operating cash flow	-12883000	Operating Cash Flow: -12883000 Open source
19951995-12-31	Operating cash flow	-17078000	Operating Cash Flow: -17078000 Open source
19961996-12-31	Operating cash flow	-20331000	Operating Cash Flow: -20331000 Open source
19971997-12-31	Operating cash flow	-29459000	Operating Cash Flow: -29459000 Open source
19981998-12-31	Operating cash flow	-1304000	Operating Cash Flow: -1304000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -9.6M 1998

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19941994-12-31	Free cash flow	-36578000	Operating Cash Flow: -12883000 Open source Capital Expenditure: 23695000 Open source
19951995-12-31	Free cash flow	-25741000	Operating Cash Flow: -17078000 Open source Capital Expenditure: 8663000 Open source
19961996-12-31	Free cash flow	-31529000	Operating Cash Flow: -20331000 Open source Capital Expenditure: 11198000 Open source
19971997-12-31	Free cash flow	-39943000	Operating Cash Flow: -29459000 Open source Capital Expenditure: 10484000 Open source
19981998-12-31	Free cash flow	-9585000	Operating Cash Flow: -1304000 Open source Capital Expenditure: 8281000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
1994-12-31	Liabilities / assets	Not reported	No source recorded
1995-12-31	Liabilities / assets	Not reported	Total Assets: 112449000 Open source
1996-12-31	Liabilities / assets	Not reported	Total Assets: 144500000 Open source
1997-12-31	Liabilities / assets	Not reported	Total Assets: 170543000 Open source
1998-12-31	Liabilities / assets	Not reported	Total Assets: 190130000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

5.03× 1998

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
1994-12-31	Current assets / current liabilities	Not reported	No source recorded
19951995-12-31	Current assets / current liabilities	2.63×	Current Assets: 56466000 Open source Current Liabilities: 21437000 Open source
19961996-12-31	Current assets / current liabilities	2.16×	Current Assets: 89871000 Open source Current Liabilities: 41672000 Open source
19971997-12-31	Current assets / current liabilities	4.28×	Current Assets: 117390000 Open source Current Liabilities: 27447000 Open source
19981998-12-31	Current assets / current liabilities	5.03×	Current Assets: 128579000 Open source Current Liabilities: 25584000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
1994 1994-01-01 – 1994-12-31	−USD 16.21 million Exact value Exact value: -16207000 USD 1994-01-01 – 1994-12-31: -16207000 USD Inspect Net Income Open source Share or cite Citation for Net Income · NEXSTAR PHARMACEUTICALS INC · 1994-12-31 NEXSTAR PHARMACEUTICALS INC (edgar:915359) Net Income: -16207000 USD Concept: fundies:NetIncome Period: 1994-01-01 to 1994-12-31 Values: Latest reported Published: 2026-11-10T02:58:16Z Snapshot: 10d6762f766f08be52a0594ecc2f9707db653b3d6600cbb2e82764f817e5d746 Dimensions: Consolidated View: https://fundies.io/companies/edgar/915359/explain?concept=fundies%3ANetIncome&period=1994-12-31&surface=latest&period_type=duration&start=1994-01-01&unit=USD&dimensions= Input fundies:NetIncome: -16207000 USD (1994-01-01 to 1994-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/915359/0000950134-97-002373.txt#4066 The citation records this snapshot. The page link may show a newer release later.	−USD 12.88 million Exact value Exact value: -12883000 USD 1994-01-01 – 1994-12-31: -12883000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NEXSTAR PHARMACEUTICALS INC · 1994-12-31 NEXSTAR PHARMACEUTICALS INC (edgar:915359) Operating Cash Flow: -12883000 USD Concept: fundies:OperatingCashFlow Period: 1994-01-01 to 1994-12-31 Values: Latest reported Published: 2026-11-10T02:58:16Z Snapshot: 10d6762f766f08be52a0594ecc2f9707db653b3d6600cbb2e82764f817e5d746 Dimensions: Consolidated View: https://fundies.io/companies/edgar/915359/explain?concept=fundies%3AOperatingCashFlow&period=1994-12-31&surface=latest&period_type=duration&start=1994-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -12883000 USD (1994-01-01 to 1994-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/915359/0000950134-97-002373.txt#4090 The citation records this snapshot. The page link may show a newer release later.	USD 23.7 million Exact value Exact value: 23695000 USD 1994-01-01 – 1994-12-31: 23695000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · NEXSTAR PHARMACEUTICALS INC · 1994-12-31 NEXSTAR PHARMACEUTICALS INC (edgar:915359) Capital Expenditure: 23695000 USD Concept: fundies:CapitalExpenditure Period: 1994-01-01 to 1994-12-31 Values: Latest reported Published: 2026-11-10T02:58:16Z Snapshot: 10d6762f766f08be52a0594ecc2f9707db653b3d6600cbb2e82764f817e5d746 Dimensions: Consolidated View: https://fundies.io/companies/edgar/915359/explain?concept=fundies%3ACapitalExpenditure&period=1994-12-31&surface=latest&period_type=duration&start=1994-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 23695000 USD (1994-01-01 to 1994-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/915359/0000950134-97-002373.txt#4093 The citation records this snapshot. The page link may show a newer release later.	−USD 36.58 million Calculation and evidence -12883000 − 23695000 USD Exact free cash flow: -36578000 USD 1994-01-01 – 1994-12-31: -12883000 USD · Inspect Operating Cash Flow · Source 1994-01-01 – 1994-12-31: 23695000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · NEXSTAR PHARMACEUTICALS INC · 1994-12-31 NEXSTAR PHARMACEUTICALS INC (edgar:915359) Free cash flow: -36578000 USD Concept: free-cash-flow Period: 1994-01-01 to 1994-12-31 Values: Latest reported Published: 2026-11-10T02:58:16Z Snapshot: 10d6762f766f08be52a0594ecc2f9707db653b3d6600cbb2e82764f817e5d746 Dimensions: Consolidated View: https://fundies.io/companies/edgar/915359?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -12883000 USD (1994-01-01 to 1994-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/915359/0000950134-97-002373.txt#4090 Input fundies:CapitalExpenditure: 23695000 USD (1994-01-01 to 1994-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/915359/0000950134-97-002373.txt#4093 The citation records this snapshot. The page link may show a newer release later.
1995 1995-01-01 – 1995-12-31	−USD 36.63 million Exact value Exact value: -36631000 USD 1995-01-01 – 1995-12-31: -36631000 USD Inspect Net Income Open source Share or cite Citation for Net Income · NEXSTAR PHARMACEUTICALS INC · 1995-12-31 NEXSTAR PHARMACEUTICALS INC (edgar:915359) Net Income: -36631000 USD Concept: fundies:NetIncome Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-10T02:58:16Z Snapshot: 10d6762f766f08be52a0594ecc2f9707db653b3d6600cbb2e82764f817e5d746 Dimensions: Consolidated View: https://fundies.io/companies/edgar/915359/explain?concept=fundies%3ANetIncome&period=1995-12-31&surface=latest&period_type=duration&start=1995-01-01&unit=USD&dimensions= Input fundies:NetIncome: -36631000 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/915359/0001035704-98-000211.txt#3990 The citation records this snapshot. The page link may show a newer release later.	−USD 17.08 million Exact value Exact value: -17078000 USD 1995-01-01 – 1995-12-31: -17078000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NEXSTAR PHARMACEUTICALS INC · 1995-12-31 NEXSTAR PHARMACEUTICALS INC (edgar:915359) Operating Cash Flow: -17078000 USD Concept: fundies:OperatingCashFlow Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-10T02:58:16Z Snapshot: 10d6762f766f08be52a0594ecc2f9707db653b3d6600cbb2e82764f817e5d746 Dimensions: Consolidated View: https://fundies.io/companies/edgar/915359/explain?concept=fundies%3AOperatingCashFlow&period=1995-12-31&surface=latest&period_type=duration&start=1995-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -17078000 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/915359/0001035704-98-000211.txt#4015 The citation records this snapshot. The page link may show a newer release later.	USD 8.66 million Exact value Exact value: 8663000 USD 1995-01-01 – 1995-12-31: 8663000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · NEXSTAR PHARMACEUTICALS INC · 1995-12-31 NEXSTAR PHARMACEUTICALS INC (edgar:915359) Capital Expenditure: 8663000 USD Concept: fundies:CapitalExpenditure Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-10T02:58:16Z Snapshot: 10d6762f766f08be52a0594ecc2f9707db653b3d6600cbb2e82764f817e5d746 Dimensions: Consolidated View: https://fundies.io/companies/edgar/915359/explain?concept=fundies%3ACapitalExpenditure&period=1995-12-31&surface=latest&period_type=duration&start=1995-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 8663000 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/915359/0001035704-98-000211.txt#4018 The citation records this snapshot. The page link may show a newer release later.	−USD 25.74 million Calculation and evidence -17078000 − 8663000 USD Exact free cash flow: -25741000 USD 1995-01-01 – 1995-12-31: -17078000 USD · Inspect Operating Cash Flow · Source 1995-01-01 – 1995-12-31: 8663000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · NEXSTAR PHARMACEUTICALS INC · 1995-12-31 NEXSTAR PHARMACEUTICALS INC (edgar:915359) Free cash flow: -25741000 USD Concept: free-cash-flow Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-10T02:58:16Z Snapshot: 10d6762f766f08be52a0594ecc2f9707db653b3d6600cbb2e82764f817e5d746 Dimensions: Consolidated View: https://fundies.io/companies/edgar/915359?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -17078000 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/915359/0001035704-98-000211.txt#4015 Input fundies:CapitalExpenditure: 8663000 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/915359/0001035704-98-000211.txt#4018 The citation records this snapshot. The page link may show a newer release later.
1996 1996-01-01 – 1996-12-31	−USD 22.98 million Exact value Exact value: -22981000 USD 1996-01-01 – 1996-12-31: -22981000 USD Inspect Net Income Open source Share or cite Citation for Net Income · NEXSTAR PHARMACEUTICALS INC · 1996-12-31 NEXSTAR PHARMACEUTICALS INC (edgar:915359) Net Income: -22981000 USD Concept: fundies:NetIncome Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-10T02:58:16Z Snapshot: 10d6762f766f08be52a0594ecc2f9707db653b3d6600cbb2e82764f817e5d746 Dimensions: Consolidated View: https://fundies.io/companies/edgar/915359/explain?concept=fundies%3ANetIncome&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:NetIncome: -22981000 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/915359/0001047469-99-025026.txt#4404 The citation records this snapshot. The page link may show a newer release later.	−USD 20.33 million Exact value Exact value: -20331000 USD 1996-01-01 – 1996-12-31: -20331000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NEXSTAR PHARMACEUTICALS INC · 1996-12-31 NEXSTAR PHARMACEUTICALS INC (edgar:915359) Operating Cash Flow: -20331000 USD Concept: fundies:OperatingCashFlow Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-10T02:58:16Z Snapshot: 10d6762f766f08be52a0594ecc2f9707db653b3d6600cbb2e82764f817e5d746 Dimensions: Consolidated View: https://fundies.io/companies/edgar/915359/explain?concept=fundies%3AOperatingCashFlow&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -20331000 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/915359/0001047469-99-025026.txt#4430 The citation records this snapshot. The page link may show a newer release later.	USD 11.2 million Exact value Exact value: 11198000 USD 1996-01-01 – 1996-12-31: 11198000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · NEXSTAR PHARMACEUTICALS INC · 1996-12-31 NEXSTAR PHARMACEUTICALS INC (edgar:915359) Capital Expenditure: 11198000 USD Concept: fundies:CapitalExpenditure Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-10T02:58:16Z Snapshot: 10d6762f766f08be52a0594ecc2f9707db653b3d6600cbb2e82764f817e5d746 Dimensions: Consolidated View: https://fundies.io/companies/edgar/915359/explain?concept=fundies%3ACapitalExpenditure&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 11198000 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/915359/0001047469-99-025026.txt#4435 The citation records this snapshot. The page link may show a newer release later.	−USD 31.53 million Calculation and evidence -20331000 − 11198000 USD Exact free cash flow: -31529000 USD 1996-01-01 – 1996-12-31: -20331000 USD · Inspect Operating Cash Flow · Source 1996-01-01 – 1996-12-31: 11198000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · NEXSTAR PHARMACEUTICALS INC · 1996-12-31 NEXSTAR PHARMACEUTICALS INC (edgar:915359) Free cash flow: -31529000 USD Concept: free-cash-flow Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-10T02:58:16Z Snapshot: 10d6762f766f08be52a0594ecc2f9707db653b3d6600cbb2e82764f817e5d746 Dimensions: Consolidated View: https://fundies.io/companies/edgar/915359?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -20331000 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/915359/0001047469-99-025026.txt#4430 Input fundies:CapitalExpenditure: 11198000 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/915359/0001047469-99-025026.txt#4435 The citation records this snapshot. The page link may show a newer release later.
1997 1997-01-01 – 1997-12-31	−USD 43.91 million Exact value Exact value: -43910000 USD 1997-01-01 – 1997-12-31: -43910000 USD Inspect Net Income Open source Share or cite Citation for Net Income · NEXSTAR PHARMACEUTICALS INC · 1997-12-31 NEXSTAR PHARMACEUTICALS INC (edgar:915359) Net Income: -43910000 USD Concept: fundies:NetIncome Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-10T02:58:16Z Snapshot: 10d6762f766f08be52a0594ecc2f9707db653b3d6600cbb2e82764f817e5d746 Dimensions: Consolidated View: https://fundies.io/companies/edgar/915359/explain?concept=fundies%3ANetIncome&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:NetIncome: -43910000 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/915359/0001047469-99-025026.txt#4404 The citation records this snapshot. The page link may show a newer release later.	−USD 29.46 million Exact value Exact value: -29459000 USD 1997-01-01 – 1997-12-31: -29459000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NEXSTAR PHARMACEUTICALS INC · 1997-12-31 NEXSTAR PHARMACEUTICALS INC (edgar:915359) Operating Cash Flow: -29459000 USD Concept: fundies:OperatingCashFlow Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-10T02:58:16Z Snapshot: 10d6762f766f08be52a0594ecc2f9707db653b3d6600cbb2e82764f817e5d746 Dimensions: Consolidated View: https://fundies.io/companies/edgar/915359/explain?concept=fundies%3AOperatingCashFlow&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -29459000 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/915359/0001047469-99-025026.txt#4430 The citation records this snapshot. The page link may show a newer release later.	USD 10.48 million Exact value Exact value: 10484000 USD 1997-01-01 – 1997-12-31: 10484000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · NEXSTAR PHARMACEUTICALS INC · 1997-12-31 NEXSTAR PHARMACEUTICALS INC (edgar:915359) Capital Expenditure: 10484000 USD Concept: fundies:CapitalExpenditure Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-10T02:58:16Z Snapshot: 10d6762f766f08be52a0594ecc2f9707db653b3d6600cbb2e82764f817e5d746 Dimensions: Consolidated View: https://fundies.io/companies/edgar/915359/explain?concept=fundies%3ACapitalExpenditure&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 10484000 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/915359/0001047469-99-025026.txt#4435 The citation records this snapshot. The page link may show a newer release later.	−USD 39.94 million Calculation and evidence -29459000 − 10484000 USD Exact free cash flow: -39943000 USD 1997-01-01 – 1997-12-31: -29459000 USD · Inspect Operating Cash Flow · Source 1997-01-01 – 1997-12-31: 10484000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · NEXSTAR PHARMACEUTICALS INC · 1997-12-31 NEXSTAR PHARMACEUTICALS INC (edgar:915359) Free cash flow: -39943000 USD Concept: free-cash-flow Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-10T02:58:16Z Snapshot: 10d6762f766f08be52a0594ecc2f9707db653b3d6600cbb2e82764f817e5d746 Dimensions: Consolidated View: https://fundies.io/companies/edgar/915359?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -29459000 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/915359/0001047469-99-025026.txt#4430 Input fundies:CapitalExpenditure: 10484000 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/915359/0001047469-99-025026.txt#4435 The citation records this snapshot. The page link may show a newer release later.
1998 1998-01-01 – 1998-12-31	USD 10.92 million Exact value Exact value: 10920000 USD 1998-01-01 – 1998-12-31: 10920000 USD Inspect Net Income Open source Share or cite Citation for Net Income · NEXSTAR PHARMACEUTICALS INC · 1998-12-31 NEXSTAR PHARMACEUTICALS INC (edgar:915359) Net Income: 10920000 USD Concept: fundies:NetIncome Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-10T02:58:16Z Snapshot: 10d6762f766f08be52a0594ecc2f9707db653b3d6600cbb2e82764f817e5d746 Dimensions: Consolidated View: https://fundies.io/companies/edgar/915359/explain?concept=fundies%3ANetIncome&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:NetIncome: 10920000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/915359/0001047469-99-025026.txt#4404 The citation records this snapshot. The page link may show a newer release later.	−USD 1.3 million Exact value Exact value: -1304000 USD 1998-01-01 – 1998-12-31: -1304000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NEXSTAR PHARMACEUTICALS INC · 1998-12-31 NEXSTAR PHARMACEUTICALS INC (edgar:915359) Operating Cash Flow: -1304000 USD Concept: fundies:OperatingCashFlow Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-10T02:58:16Z Snapshot: 10d6762f766f08be52a0594ecc2f9707db653b3d6600cbb2e82764f817e5d746 Dimensions: Consolidated View: https://fundies.io/companies/edgar/915359/explain?concept=fundies%3AOperatingCashFlow&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1304000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/915359/0001047469-99-025026.txt#4430 The citation records this snapshot. The page link may show a newer release later.	USD 8.28 million Exact value Exact value: 8281000 USD 1998-01-01 – 1998-12-31: 8281000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · NEXSTAR PHARMACEUTICALS INC · 1998-12-31 NEXSTAR PHARMACEUTICALS INC (edgar:915359) Capital Expenditure: 8281000 USD Concept: fundies:CapitalExpenditure Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-10T02:58:16Z Snapshot: 10d6762f766f08be52a0594ecc2f9707db653b3d6600cbb2e82764f817e5d746 Dimensions: Consolidated View: https://fundies.io/companies/edgar/915359/explain?concept=fundies%3ACapitalExpenditure&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 8281000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/915359/0001047469-99-025026.txt#4435 The citation records this snapshot. The page link may show a newer release later.	−USD 9.59 million Calculation and evidence -1304000 − 8281000 USD Exact free cash flow: -9585000 USD 1998-01-01 – 1998-12-31: -1304000 USD · Inspect Operating Cash Flow · Source 1998-01-01 – 1998-12-31: 8281000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · NEXSTAR PHARMACEUTICALS INC · 1998-12-31 NEXSTAR PHARMACEUTICALS INC (edgar:915359) Free cash flow: -9585000 USD Concept: free-cash-flow Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-10T02:58:16Z Snapshot: 10d6762f766f08be52a0594ecc2f9707db653b3d6600cbb2e82764f817e5d746 Dimensions: Consolidated View: https://fundies.io/companies/edgar/915359?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -1304000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/915359/0001047469-99-025026.txt#4430 Input fundies:CapitalExpenditure: 8281000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/915359/0001047469-99-025026.txt#4435 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

15 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-10. Source filing dates and reporting periods are shown separately.

Identifiers: 0000915359, 915359, edgar:915359

NEXSTAR PHARMACEUTICALS INC

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Trailing twelve months

Revenue

Net income

Operating cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

1998 1998-01-01 – 1998-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation